Citigroup's (C) Buy (B) Rating Reiterated at Weiss Ratings

Key Points

• Citigroup has received a "buy" rating from Weiss Ratings, reaffirming positive sentiment among analysts.
• Bank of America recently increased its price target for Citigroup from $89 to $100, indicating strong confidence in the stock's potential.
• The company reported an EPS of $1.96 for the last quarter, exceeding analyst expectations and showing substantial year-over-year revenue growth of 8.2%.

Citigroup (NYSE:C - Get Free Report)'s stock had its "buy (b)" rating reissued by Weiss Ratings in a note issued to investors on Wednesday,Weiss Ratings reports.

Several other research firms also recently weighed in on C. Bank of America raised their price target on shares of Citigroup from $89.00 to $100.00 and gave the stock a "buy" rating in a research note on Thursday, June 26th. TD Cowen upped their price objective on shares of Citigroup from $85.00 to $95.00 and gave the stock a "hold" rating in a research report on Wednesday, July 16th. Keefe, Bruyette & Woods reissued a "buy" rating on shares of Citigroup in a research note on Wednesday, July 16th. Truist Financial raised their target price on shares of Citigroup from $105.00 to $112.00 and gave the stock a "buy" rating in a research report on Wednesday, September 24th. Finally, Evercore ISI set a $77.00 price objective on shares of Citigroup in a research note on Monday, July 7th. Eleven equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $99.68.

Citigroup Trading Down 1.2%

NYSE:C traded down $1.13 during mid-day trading on Wednesday, hitting $96.67. 8,489,079 shares of the stock traded hands, compared to its average volume of 13,029,077. The company has a quick ratio of 0.99, a current ratio of 0.99 and a debt-to-equity ratio of 1.61. The stock has a market capitalization of $177.96 billion, a price-to-earnings ratio of 14.28, a PEG ratio of 0.85 and a beta of 1.37. The firm's 50 day moving average is $96.92 and its two-hundred day moving average is $83.43. Citigroup has a 52 week low of $55.51 and a 52 week high of $105.59.

Citigroup (NYSE:C - Get Free Report) last issued its earnings results on Tuesday, July 15th. The company reported $1.96 EPS for the quarter, topping analysts' consensus estimates of $1.61 by $0.35. Citigroup had a net margin of 8.44% and a return on equity of 7.29%. The business had revenue of $21.67 billion for the quarter, compared to the consensus estimate of $20.75 billion. During the same period in the prior year, the firm earned $1.52 EPS. The company's revenue for the quarter was up 8.2% compared to the same quarter last year. Citigroup has set its FY 2025 guidance at EPS. On average, equities research analysts predict that Citigroup will post 7.53 earnings per share for the current year.

Insider Transactions at Citigroup

In other Citigroup news, Director Peter B. Henry sold 3,000 shares of the business's stock in a transaction on Wednesday, July 16th. The stock was sold at an average price of $90.40, for a total value of $271,200.00. Following the transaction, the director owned 2,140 shares of the company's stock, valued at approximately $193,456. The trade was a 58.37% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.08% of the company's stock.

Institutional Trading of Citigroup

Several large investors have recently modified their holdings of C. MorganRosel Wealth Management LLC purchased a new position in shares of Citigroup in the first quarter valued at about $28,000. Accent Capital Management LLC lifted its holdings in Citigroup by 106.0% during the first quarter. Accent Capital Management LLC now owns 412 shares of the company's stock worth $29,000 after buying an additional 212 shares during the period. Truvestments Capital LLC lifted its holdings in shares of Citigroup by 131.6% during the 1st quarter. Truvestments Capital LLC now owns 433 shares of the company's stock valued at $31,000 after purchasing an additional 246 shares during the last quarter. Howard Hughes Medical Institute purchased a new position in Citigroup in the 2nd quarter worth $34,000. Finally, DHJJ Financial Advisors Ltd. grew its position in Citigroup by 157.1% during the 2nd quarter. DHJJ Financial Advisors Ltd. now owns 414 shares of the company's stock worth $35,000 after purchasing an additional 253 shares during the period. Institutional investors own 71.72% of the company's stock.

About Citigroup

Citigroup Inc, a diversified financial service holding company, provides various financial product and services to consumers, corporations, governments, and institutions worldwide. It operates through five segments: Services, Markets, Banking, U.S. Personal Banking, and Wealth. The Services segment includes Treasury and Trade Solutions, which provides cash management, trade, and working capital solutions to multinational corporations, financial institutions, and public sector organizations; and Securities Services, such as cross-border support for clients, local market expertise, post-trade technologies, data solutions, and various securities services solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.